Discover why BTK inhibitors have attracted interest for treating multiple sclerosis, as a few late-stage candidates close in ...

A lower limb neurological exam is a key part of the physical examination used to assess the function of the central and peripheral nervous systems related to the legs. It evaluates motor function, ...

Tolebrutinib is an oral, brain-penetrant, and bioactive Bruton’s tyrosine kinase inhibitor that modulates peripheral inflammation ... in treating relapsing multiple sclerosis.

Damage to myelin, whether from genetic disorders or injury, can lead to progressive pain, muscle weakness and disability, as seen in conditions such as multiple sclerosis and several peripheral nerve ...

The New England Journal of Medicine (NEJM) published positive results from the HERCULES phase 3 study demonstrating that tolebrutinib delayed disability progression in people with non-relapsing ...

Tolebrutinib, a novel BTK inhibitor that targets neuroinflammation, slowed disability progression by 31% in nrSPMS, a phase 3 ...

Neuroimmune modulation represents a promising treatment strategy that uses vagus nerve stimulation to reduce inflammation in ...

New Report Highlights the Science Behind Nerve Freedom-A Natural Supplement Aimed at Supporting Long-Term Nerve Health Without Harsh Side Effects< ...

Sanofi announces tolebrutinib phase 3 study data published in NEJM shows benefit on disability progression in multiple sclerosis: Paris Thursday, April 10, 2025, 10:00 Hrs [IST] T ...

As they described in Radiology Case Reports, the patient noted that she had been having increasing weakness in her left arm ...